149 related articles for article (PubMed ID: 12111792)
1. Monoclonal gammopathy after low-grade MALT lymphoma: evidence for a second neoplasm.
Pachmann S; Anderegg B; Müller-Höcker J; Nathrath W; Brack N; Tigges FJ; Hartenstein R; Munker R
Am J Hematol; 2002 Jun; 70(2):167-73. PubMed ID: 12111792
[TBL] [Abstract][Full Text] [Related]
2. [MALT B cell lymphoma with kidney damage and monoclonal gammopathy: a case study and literature review].
Peces R; Vega-Cabrera C; Peces C; Pobes A; Fresno MF
Nefrologia; 2010; 30(6):681-6. PubMed ID: 21113219
[TBL] [Abstract][Full Text] [Related]
3. Ongoing monoclonal B-cell proliferation is not common in gastric B-cell lymphoma after combined radiochemotherapy.
Alpen B; Kuse R; Parwaresch R; Müller-Hermelink HK; Stolte M; Neubauer A
J Clin Oncol; 2004 Aug; 22(15):3039-45. PubMed ID: 15284253
[TBL] [Abstract][Full Text] [Related]
4. T-cell lymphoid aggregates in bone marrow after rituximab therapy for B-cell follicular lymphoma: a marker of therapeutic efficacy?
Raynaud P; Caulet-Maugendre S; Foussard C; Salles G; Moreau A; Rossi JF; Patey M; Rousselet MC; Bene MC; Damotte D; Cornillet Lefebvre P; Martin A; Costes V;
Hum Pathol; 2008 Feb; 39(2):194-200. PubMed ID: 17949786
[TBL] [Abstract][Full Text] [Related]
5. Systemic CD5+ MALT lymphoma: presentation with Waldenstrom syndrome.
Mikolaenko I; Listinsky CM
Ann Diagn Pathol; 2009 Aug; 13(4):272-7. PubMed ID: 19608087
[TBL] [Abstract][Full Text] [Related]
6. Waldenström macroglobulinemia caused by extranodal marginal zone B-cell lymphoma: a report of six cases.
Valdez R; Finn WG; Ross CW; Singleton TP; Tworek JA; Schnitzer B
Am J Clin Pathol; 2001 Nov; 116(5):683-90. PubMed ID: 11710684
[TBL] [Abstract][Full Text] [Related]
7. Necrobiotic xanthogranuloma associated with paraproteinemia and non-Hodgkin's lymphoma developing into chronic lymphocytic leukemia: the first case reported in the literature and review of the literature.
Oumeish OY; Oumeish I; Tarawneh M; Salman T; Sharaiha A
Int J Dermatol; 2006 Mar; 45(3):306-10. PubMed ID: 16533236
[TBL] [Abstract][Full Text] [Related]
8. Activity of rituximab plus cyclophosphamide, doxorubicin/mitoxantrone, vincristine and prednisone in patients with relapsed MALT lymphoma.
Raderer M; Wohrer S; Streubel B; Drach J; Jager U; Turetschek K; Troch M; Puspok A; Zielinski CC; Chott A
Oncology; 2006; 70(6):411-7. PubMed ID: 17220639
[TBL] [Abstract][Full Text] [Related]
9. Biclonal low grade B-cell lymphoma confirmed by both flow cytometry and karyotypic analysis, in spite of a normal kappa/lambda Ig light chain ratio.
Delville JP; Heimann P; El Housni H; Boutriaux M; Jeronnez A; Remmelink M; Lasudry J; Pradier O; Kentos A
Am J Hematol; 2007 Jun; 82(6):473-80. PubMed ID: 17211842
[TBL] [Abstract][Full Text] [Related]
10. Systemic eight-cycle anti-CD20 monoclonal antibody (rituximab) therapy in primary cutaneous B-cell lymphomas--an applicational observation.
Gellrich S; Muche JM; Wilks A; Jasch KC; Voit C; Fischer T; Audring H; Sterry W
Br J Dermatol; 2005 Jul; 153(1):167-73. PubMed ID: 16029344
[TBL] [Abstract][Full Text] [Related]
11. [Relapse of diffuse large B cell lymphoma to CD20-negative multiple cutaneous tumors immediately after anti-CD20 monoclonal antibody (rituximab) therapy].
Iguchi T; Miyazawa K; Okabe S; Kawakubo K; Shimamoto T; Kuriyama Y; Ito Y; Kimura Y; Ohyashiki K; Serizawa H; Iwaya K; Mukai K
Rinsho Ketsueki; 2004 Oct; 45(10):1129-34. PubMed ID: 15553050
[TBL] [Abstract][Full Text] [Related]
12. Nongastric marginal-zone B-cell MALT lymphoma: prognostic value of disease dissemination.
Arcaini L; Burcheri S; Rossi A; Passamonti F; Paulli M; Boveri E; Brusamolino E; Orlandi E; Molteni A; Pulsoni A; Cox MC; Orsucci L; Fabbri A; Frezzato M; Voso MT; Zaja F; Montanari F; Pascutto C; Morra E; Cortelazzo S; Lazzarino M
Oncologist; 2006 Mar; 11(3):285-91. PubMed ID: 16549813
[TBL] [Abstract][Full Text] [Related]
13. [A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab].
Kanaji N; Ishibashi K; Uno H; Hino N
Gan To Kagaku Ryoho; 2002 Dec; 29(13):2569-72. PubMed ID: 12506485
[TBL] [Abstract][Full Text] [Related]
14. Combined histology and molecular biology for diagnosis of early stage gastric MALT lymphoma.
Yi ZH; Ouyang Q; Li GD; Chen DY
Chin J Dig Dis; 2006; 7(1):12-8. PubMed ID: 16412032
[TBL] [Abstract][Full Text] [Related]
15. [Complete remission of relapsed mixed cellularity Hodgkin's disease treated with rituximab].
Al-Ali HK; Wittekind C; Niederwieser D
Dtsch Med Wochenschr; 2007 Aug; 132(33):1688-91. PubMed ID: 17713864
[TBL] [Abstract][Full Text] [Related]
16. [Disappearance of CD 20 after treatment with rituximab of mantle cell lymphoma].
Yoshida K; Kayano H; Shimada T; Wakao D; Takahashi N; Sugahara Y; Yagasaki F; Ito Y; Kawai N; Matsuda A; Suzuki T; Bessho M
Rinsho Ketsueki; 2003 Mar; 44(3):174-81. PubMed ID: 12722344
[TBL] [Abstract][Full Text] [Related]
17. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous regression of intraoral mucosa-associated lymphoid tissue lymphoma: molecular study of a case.
Sakuma H; Okabe M; Yokoi M; Eimoto T; Inagaki H
Pathol Int; 2006 Jun; 56(6):331-5. PubMed ID: 16704497
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy with rituximab and intravenous or oral fludarabine in the first-line, systemic treatment of patients with extranodal marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue type.
Salar A; Domingo-Domenech E; Estany C; Canales MA; Gallardo F; Servitje O; Fraile G; Montalbán C
Cancer; 2009 Nov; 115(22):5210-7. PubMed ID: 19672998
[TBL] [Abstract][Full Text] [Related]
20. Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT lymphoma) arising in the small intestine with monoclonal cryoglobulinemia.
Saito T; Tamaru J; Kishi H; Kayao J; Kuzuu Y; Wakita H; Adachi A; Itoyama S; Mikata I
Pathol Int; 2004 Sep; 54(9):712-8. PubMed ID: 15363040
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
